Atherogenic risk factors in cerebrotendinous xanthomatosis
Authors:
- 1 August 1991
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 200 (1) , 1-11
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literatureJournal of the Neurological Sciences, 1991
- Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisMetabolism, 1987
- Peripheral Neuropathy in Cerebrotendinous XanthomatosisArchives of Neurology, 1985
- A unique patient with coexisting cerebrotendinous xanthomatosis and β-sitosterolemiaThe American Journal of Medicine, 1981
- Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.Journal of Clinical Investigation, 1980
- Cholic Acid BiosynthesisJournal of Clinical Investigation, 1979
- Cholestanol Deposition in Cerebrotendinous XanthomatosisAnnals of Internal Medicine, 1971
- Familial Pseudohypertrophy of Tendo-Achillis with Multisystem DiseaseSouthern Medical Journal, 1971
- SUBCELLULAR DISTRIBUTION OF CEREBRAL CHOLE‐STANOL IN CEREBROTENDINOUS XANTHOMATOSISJournal of Neurochemistry, 1971
- Cerebrotendinous XanthomatosisArchives of Neurology, 1968